These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15337304)

  • 1. Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats.
    Bednar I; Friberg L; Nordberg A
    Neurochem Int; 2004 Dec; 45(7):1049-55. PubMed ID: 15337304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of epibatidine and nicotine on the output of dopamine in the dorsal and ventral striatum of freely-moving rats.
    Seppä T; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):444-7. PubMed ID: 11111841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
    Janhunen S; Ahtee L
    Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine and epibatidine alter differently nomifensine-elevated dopamine output in the rat dorsal and ventral striatum.
    Janhunen S; Tuominen RK; Piepponen TP; Ahtee L
    Eur J Pharmacol; 2005 Mar; 511(2-3):143-50. PubMed ID: 15792782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
    Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
    J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens.
    Preda S; Govoni S; Lanni C; Racchi M; Mura E; Grilli M; Marchi M
    Neuropsychopharmacology; 2008 Apr; 33(5):1062-70. PubMed ID: 17581530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration.
    Jacobs I; Anderson DJ; Surowy CS; Puttfarcken PS
    Neuropharmacology; 2002 Oct; 43(5):847-56. PubMed ID: 12384170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
    Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
    Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release.
    Grilli M; Parodi M; Raiteri M; Marchi M
    J Neurochem; 2005 Jun; 93(5):1353-60. PubMed ID: 15934954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
    Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum.
    Puttfarcken PS; Jacobs I; Faltynek CR
    Neuropharmacology; 2000 Oct; 39(13):2673-80. PubMed ID: 11044737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist.
    Invernizzi R; Pozzi L; Samanin R
    Neuropharmacology; 1995 Feb; 34(2):211-5. PubMed ID: 7617146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens.
    Mirza NR; Pei Q; Stolerman IP; Zetterström TS
    Eur J Pharmacol; 1996 Jan; 295(2-3):207-10. PubMed ID: 8720585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
    Hildebrand BE; Svensson TH
    J Neural Transm (Vienna); 2000; 107(8-9):861-72. PubMed ID: 11041268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
    Kommalage M; Höglund AU
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.
    Fu Y; Matta SG; Gao W; Brower VG; Sharp BM
    J Pharmacol Exp Ther; 2000 Aug; 294(2):458-65. PubMed ID: 10900219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol-induced dopamine elevation in the rat--modulatory effects by subchronic treatment with nicotinic drugs.
    Löf E; Chau PP; Stomberg R; Söderpalm B
    Eur J Pharmacol; 2007 Jan; 555(2-3):139-47. PubMed ID: 17141214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.